The estimated Net Worth of Jack W Lasersohn is at least $513 Mille dollars as of 3 June 2021. Mr. Lasersohn owns over 5,427 units of Silk Road Medical Inc stock worth over $129,908 and over the last 17 years he sold SILK stock worth over $247,471. In addition, he makes $136,068 as Independent Director at Silk Road Medical Inc.
Jack has made over 5 trades of the Silk Road Medical Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 5,427 units of SILK stock worth $247,471 on 3 June 2021.
The largest trade he's ever made was buying 34,614 units of Silk Road Medical Inc stock on 25 May 2017 worth over $116,649. On average, Jack trades about 2,225 units every 87 days since 2007. As of 3 June 2021 he still owns at least 4,769 units of Silk Road Medical Inc stock.
You can see the complete history of Mr. Lasersohn stock trades at the bottom of the page.
Jack W. Lasersohn J.D. serves as Independent Director of the Company. Mr. Lasersohn has been a general partner, or a principal of the general partner, of The Vertical Group, L.P., a private venture capital firm that is focused on the fields of medical technology and biotechnology. The Vertical Group was a co-founder of our company. Prior to joining The Vertical Group’s predecessor, F. Eberstadt, in 1981, Mr. Lasersohn was a corporate attorney with Cravath, Swaine & Moore LLP. Mr. Lasersohn served on the board of directors of Masimo Corporation, a publicly traded global medical technology company, from January 1995 to 2017 and has served on the board of directors of OncoMed Pharmaceuticals, Inc., a publicly traded clinical development-stage biopharmaceutical company, since July 2005. He also serves on the boards of a number of private medical device and biotechnology companies. Mr. Lasersohn is the past Chairman of the Medical Industry Group of the National Venture Capital Association, or NVCA, and previously served on the Executive Committee of the board of directors of the NVCA. Mr. Lasersohn has also served, by appointment, on various committees advising the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services.
As the Independent Director of Silk Road Medical Inc, the total compensation of Jack Lasersohn at Silk Road Medical Inc is $136,068. There are 7 executives at Silk Road Medical Inc getting paid more, with Erica Rogers having the highest compensation of $3,679,060.
Jack Lasersohn is 66, he's been the Independent Director of Silk Road Medical Inc since . There are no older and 13 younger executives at Silk Road Medical Inc.
Jack's mailing address filed with the SEC is C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE, CA, 94089.
Over the last 6 years, insiders at Silk Road Medical Inc have traded over $925,682,871 worth of Silk Road Medical Inc stock and bought 14,200 units worth $302,033 . The most active insiders traders include X Finance, L.P.Wpx Gp, L.P...., Pincus & Co.Kaye Charles R ... e Pincus & Co.Warburg Pincus .... On average, Silk Road Medical Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,280,712. The most recent stock trade was executed by Kevin M Klemz on 19 August 2024, trading 2,268 units of SILK stock currently worth $61,463.
silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th
Silk Road Medical Inc executives and other stock owners filed with the SEC include: